Indonesia
· Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 876.84 billion. The enterprise value is 1.38 trillion.
| Market Cap | 876.84B |
| Enterprise Value | 1.38T |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 3.15 billion shares outstanding.
| Current Share Class | 3.15B |
| Shares Outstanding | 3.15B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 81.58% |
| Owned by Institutions (%) | 0.02% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.05.
| PE Ratio | 8.05 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | 1.49 |
| P/OCF Ratio | 1.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.01, with an EV/FCF ratio of 2.35.
| EV / Earnings | 12.67 |
| EV / Sales | 0.50 |
| EV / EBITDA | 5.01 |
| EV / EBIT | 8.88 |
| EV / FCF | 2.35 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.37 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 2.43 |
| Debt / FCF | 1.14 |
| Interest Coverage | 4.67 |
Financial Efficiency
Return on equity (ROE) is 4.53% and return on invested capital (ROIC) is 3.17%.
| Return on Equity (ROE) | 4.53% |
| Return on Assets (ROA) | 2.81% |
| Return on Invested Capital (ROIC) | 3.17% |
| Return on Capital Employed (ROCE) | 5.38% |
| Revenue Per Employee | 3.33B |
| Profits Per Employee | 132.15M |
| Employee Count | 808 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 30.81 billion in taxes.
| Income Tax | 30.81B |
| Effective Tax Rate | 22.06% |
Stock Price Statistics
The stock price has decreased by -4.14% in the last 52 weeks. The beta is 0.65, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -4.14% |
| 50-Day Moving Average | 265.80 |
| 200-Day Moving Average | 281.90 |
| Relative Strength Index (RSI) | 60.83 |
| Average Volume (20 Days) | 448,150 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.74 trillion and earned 108.89 billion in profits. Earnings per share was 34.52.
| Revenue | 2.74T |
| Gross Profit | 382.07B |
| Operating Income | 155.36B |
| Pretax Income | 139.71B |
| Net Income | 108.89B |
| EBITDA | 269.49B |
| EBIT | 155.36B |
| Earnings Per Share (EPS) | 34.52 |
Balance Sheet
The company has 165.45 billion in cash and 668.53 billion in debt, giving a net cash position of -503.07 billion or -159.50 per share.
| Cash & Cash Equivalents | 165.45B |
| Total Debt | 668.53B |
| Net Cash | -503.07B |
| Net Cash Per Share | -159.50 |
| Equity (Book Value) | 2.44T |
| Book Value Per Share | 772.88 |
| Working Capital | 848.19B |
Cash Flow
In the last 12 months, operating cash flow was 618.34 billion and capital expenditures -30.51 billion, giving a free cash flow of 587.83 billion.
| Operating Cash Flow | 618.34B |
| Capital Expenditures | -30.51B |
| Free Cash Flow | 587.83B |
| FCF Per Share | 186.37 |
Margins
Gross margin is 13.93%, with operating and profit margins of 5.67% and 3.97%.
| Gross Margin | 13.93% |
| Operating Margin | 5.67% |
| Pretax Margin | 5.09% |
| Profit Margin | 3.97% |
| EBITDA Margin | 9.83% |
| EBIT Margin | 5.67% |
| FCF Margin | 21.44% |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 4.35%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 4.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 34.68% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.35% |
| Earnings Yield | 12.42% |
| FCF Yield | 67.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.
| Last Split Date | Jun 15, 2022 |
| Split Type | Forward |
| Split Ratio | 1.13 |
Scores
PT Suparma Tbk has an Altman Z-Score of 2.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 6 |